3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Triple Negative Breast Neoplasms
2
Sarcoma
2
Rhabdomyosarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Hodgkin Disease
2
Burkitt Lymphoma
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Teratoma
1
Sarcoma, Ewing
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pain
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasms, Germ Cell and Embryonal
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Heart Failure
1
Glioma
1
Fallopian Tube Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Dendritic Cell Sarcoma, Interdigitating
1
Choriocarcinoma
1
Central Nervous System Neoplasms
1
Cardiotoxicity
1
Interventions
Etoposide
4
Cisplatin
4
lutetium Lu 177 dotatate
2
fludarabine phosphate
2
fludarabine
2
Cyclophosphamide
2
Bleomycin
2
repotrectinib
1
pegfilgrastim
1
etoposide phosphate
1
copper dotatate CU-64
1
Watchful Waiting
1
Vorinostat
1
Teniposide
1
Surveys and Questionnaires
1
Standard of Care
1
Specimen Handling
1
Respiratory Physiological Phenomena
1
Practice Guidelines as Topic
1
Platinum
1
Nivolumab
1
Mesna
1
Magnetic Resonance Spectroscopy
1
Lutetium-177
1
Lutetium
1
Injections
1
Immunotherapy
1
Filgrastim
1
Drug Therapy
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplasms, Germ Cell and Embryonal
×
pegfilgrastim
×
Clear all
NCT02582697
2025-06-15
P3BEP
University of Sydney
Phase 3
Recruiting
500 enrolled